(NYSEMKT: INFU) Infusystem Holdings's forecast annual revenue growth rate of 6.96% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Infusystem Holdings's revenue in 2026 is $143,436,000.On average, 7 Wall Street analysts forecast INFU's revenue for 2026 to be $2,983,353,165, with the lowest INFU revenue forecast at $2,844,879,326, and the highest INFU revenue forecast at $3,094,738,691. On average, 7 Wall Street analysts forecast INFU's revenue for 2027 to be $3,211,986,614, with the lowest INFU revenue forecast at $3,045,009,400, and the highest INFU revenue forecast at $3,406,860,746.
In 2028, INFU is forecast to generate $3,598,904,757 in revenue, with the lowest revenue forecast at $3,457,802,947 and the highest revenue forecast at $3,704,832,190.